Case report: Novel <i>junctional sarcoplasmic reticulum protein 1</i> intergenic region<i>-anaplastic lymphoma kinase</i> fusion in a patient with lung adenocarcinoma responds to alectinib. Here, ALK is linked to lung adenocarcinoma.